A detailed history of Royal Bank Of Canada transactions in Procaps Group, S.A. stock. As of the latest transaction made, Royal Bank Of Canada holds 491 shares of PROC stock, worth $873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
491
Previous 362 35.64%
Holding current value
$873
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.51 - $2.97 $323 - $383
129 Added 35.64%
491 $1,000
Q1 2024

Nov 05, 2024

SELL
$2.78 - $4.7 $358 - $606
-129 Reduced 26.27%
362 $1,000
Q1 2024

May 15, 2024

BUY
$2.78 - $4.7 $436 - $737
157 Added 76.59%
362 $1,000
Q4 2023

Feb 14, 2024

BUY
$2.18 - $4.14 $274 - $521
126 Added 159.49%
205 $0
Q3 2023

Nov 14, 2023

BUY
$3.5 - $4.31 $276 - $340
79 New
79 $0
Q1 2022

May 16, 2022

SELL
$7.97 - $9.85 $310 - $384
-39 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$8.85 - $10.42 $345 - $406
39 New
39 $0

Others Institutions Holding PROC

About Procaps Group, S.A.


  • Ticker PROC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 112,824,000
  • Market Cap $201M
  • Description
  • Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...
More about PROC
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.